Defining treatment‐resistant depression

Gaynes, Bradley N., Lux, Linda, Gartlehner, Gerald, Asher, Gary, Forman‐Hoffman, Valerie, Green, Josh, Boland, Erin, Weber, Rachel P. +5 more·2020·Depression and Anxiety
DOI 10.1002/da.22968

Cited by (446)

Items 201–300 of 446

  1. Abnormal choroid plexus, hippocampus, and lateral ventricles volumes as markers of treatment‐resistant major depressive disorder
    Beatrice Bravi, Marco Paolini, Melania Maccario, Chiara Milano, Laura Raffaelli, Elisa Maria Teresa Melloni, Raffaella Zanardi, Cristina Colombo, Francesco Benedetti · 2024 · Psychiatry and Clinical Neurosciences
  2. Revealing the Mechanism of Hemerocallis citrina Baroni in Depression Treatment Through Integrated Network Pharmacology and Transcriptomic Analysis
    Shan Gao, Jihui Lu, Yixiao Gu, Yaozhi Zhang, Cheng Wang, Feng Gao, Ziqi Dai, Shujing Xu, Jindong Zhang, Yuqin Yang et al. · 2024 · Pharmaceuticals
  3. Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers
    Juliana Lima Constantino, Jens H. van Dalfsen, Sara Massetti, Jeanine Kamphuis, Robert A. Schoevers · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  4. The Targets of Deep Brain Stimulation in the Treatment of Treatment‐Resistant Depression: A Review
    Jianyang Dong, Mengying Dai, Zinan Guo, Ting Xu, Fangming Li, Jianjun Li · 2025 · Brain and Behavior
  5. Neuroprotective and gastroprotective effects of rutin and fluoxetine Co-supplementation: A biochemical analysis in Nauphoeta cinerea
    Carlos Alonso Leite dos Santos, Antonia Adeublena de Araújo Monteiro, Mateus Santana de Deus, Jean Paul Kamdem, Antônia Eliene Duarte, Mashal M. Almutairi, Abid Ali, Mohammad Ibrahim · 2025 · NeuroToxicology
  6. Exploring Biological Risk Factors in Treatment-Resistant Depression
    F. J. Liévanos-Ruiz, B. Fenton-Navarro · 2025 · Psychiatry International
  7. Right dorsolateral prefrontal cortex volumetric reduction is associated with antidepressant effect of low-dose ketamine infusion: A randomized, double-blind, midazolam-controlled PET-MRI clinical trial
    Wei‐Chi Li, Li‐Fen Chen, Tung‐Ping Su, Cheng‐Ta Li, Wei‐Chen Lin, Hui-Ju Wu, Shih‐Jen Tsai, Ya‐Mei Bai, Pei‐Chi Tu, Mu‐Hong Chen · 2023 · Journal of Affective Disorders
  8. Inflammatory pathology in depression and suicide: a mechanistic distillation of clinical correlates
    Alessandra Costanza, Andrea Amerio, Andrea Aguglia, Luca Magnani, Alberto Parise, Khoa D. Nguyen, Isabella Berardelli, Maurizio Pompili, Mario Amore, Gianluca Serafini · 2024 · Frontiers in Immunology
  9. Clinical Guidelines of the Egyptian Psychiatric Association for the Management of Treatment-Resistant Unipolar Depression in Egypt
    Momtaz Ahmed AbdelWahab, Tarek Ahmed Okasha, Mostafa O. Shaheen, Mohamed Nasr, Tarek Molokheya, Abd ElNasser Omar, Menan A. Rabie, Victor Samy Mikhael, Hany Hamed, Mohamed Gamal Ali · 2022 · Frontiers in Psychiatry
  10. Trajectories of Efficacy and Cognitive Function During Electroconvulsive Therapy Course in Young Adults with Treatment-Resistant Depression
    Shu‐xian Xu, Xin‐hui Xie, Lihua Yao, Li-chang Chen, Qirong Wan, Zhenhua Chen, Zhongchun Liu · 2023 · Neuropsychiatric Disease and Treatment
  11. Electroconvulsive Therapy for Treatment-Resistant Depression: Dispelling the Stigma.
    Deborah A. Salani, D. Goldin, Beatriz Valdes, J. DeSantis · 2023 · Journal of Psychosocial Nursing and Mental Health Services
  12. Serum nitric oxide levels are depleted in depressed patients treated with electroconvulsive therapy
    MURAT İLHAN ATAGÜN, Özge Canbek, Özlem Devrim Balaban, Derya İpekçioğlu, Baris Alpugan, Suat Yalcin, Almila Şenat, Nesrin Karamustafalıoğlu, Mehmet Cem İlnem, Özcan Erel · 2021 · Indian Journal of Psychiatry
  13. Rethinking treatment-resistant depression to quasi-tenacious depression
    Shokouh Arjmand, Rodrigo Grassi‐Oliveira, Gregers Wegener · 2023 · European Psychiatry
  14. Nitrous oxide for the treatment of depression: a systematic review and meta-analysis
    Kiranpreet Gill, Angharad N. de Cates, Chantelle Elizabeth Wiseman, Susannah Elinor Murphy, Ella Williams, Catherine J. Harmer, Isabel Morales‐Muñoz, Steven Marwaha · 2025 · EBioMedicine
  15. Multiomics and blood-based biomarkers of electroconvulsive therapy in severe and treatment-resistant depression: study protocol of the DetECT study
    Iven-Alex von Mücke-Heim, Julius C. Pape, Norma Christine Grandi, Angelika Erhardt, Jan M. Deussing, Elisabeth B. Binder · 2023 · European Archives of Psychiatry and Clinical Neuroscience
  16. Comparative Efficacy of Dopamine Partial Agonists by Doses for Treatment-Resistant Depression
    Itsuki Terao, Wakako Kodama · 2024 · Journal of Clinical Psychopharmacology
  17. Aspirin-triggered lipoxin A4 reduces neuropathic pain and anxiety-like behaviours in male diabetic rats: antinociceptive enhancement by cannabinoid receptor agonists
    Matheus Vinícius Ferreira, Carlos Henrique Alves Jesus, Jaderson Pedro Bonfim da Costa, Gabrielle Oliveira, Bruno Liebl, Waldiceu Aparecido Verri Jr, Janaína Menezes Zanoveli, Joice Maria da Cunha · 2025 · European Journal of Pharmacology
  18. The use of sequential pharmacotherapy for the treatment of acute major depression: a scoping review
    Brett D. M. Jones, Muhammad Ishrat Husain, Benoit H. Mulsant · 2021 · Expert Opinion on Pharmacotherapy
  19. Changes in adipokine concentrations in antidepressant-resistant bipolar depression after ketamine infusion and electroconvulsive therapy
    M. Dmitrzak-Węglarz, M. Tyszkiewicz-Nwafor, F. Rybakowski, Agnieszka Permoda-Pachuta · 2022 · World Journal of Biological Psychiatry
  20. 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs
    Raúl López‐Arnau, Jordi Camarasa, Marcel·lí Carbó, Núria Nadal‐Gratacós, Pol Puigseslloses, María Espinosa‐Velasco, Edurne Urquizu, Elena Escubedo, David Pubill · 2022 · Frontiers in Psychiatry
  21. Which clinical factors and biochemical parameters are associated with late-life major depression?
    Massimiliano Buoli, Francesca Legnani, Guido Nosari, Anna Pan, Valentina Ciappolino, Cecilia Maria Esposito, Alessandro Ceresa, Martina Di Paolo, Teresa Surace, Anna Maria Auxilia et al. · 2023 · International Journal of Psychiatry in Clinical Practice
  22. Prospective study of antidepressant treatment of psychiatric patients with depressive disorders: treatment adequacy and outcomes
    Johanna von Knorring, Ilya Baryshnikov, Pekka J. Jylhä, Tiina Talaslahti, Martti E. Heikkinen, Erkki Tapio Isometsä · 2023 · BMC Psychiatry
  23. Treatment resistant depression
    Sophie R. Vaccarino, Sidney H. Kennedy · 2020 · Elsevier eBooks
  24. Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
    Sumaya Jobnah, Youssef Latifeh, Dina Al Kabani, Lama A. Youssef · 2024 · BMC Psychiatry
  25. Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex
    Maria Luca, Antonina Luca, A. Messina, Lucie Bartova, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Panagiotis P. Ferentinos, Dan Rujescu et al. · 2025 · Journal of Affective Disorders
  26. Intracranial closed-loop neuromodulation as an intervention for neuropsychiatric disorders: an overview
    Jenna Langbein, Ujwal Boddeti, Weizhen Xie, Alexander Ksendzovsky · 2025 · Frontiers in Psychiatry
  27. Cardiovascular Risk Predicts White Matter Hyperintensities, Brain Atrophy and Treatment Resistance in Major Depressive Disorder: Role of Genetic Liability
    Marco Paolini, Melania Maccario, Virginia Saredi, Anna Verri, Federico Calesella, Laura Raffaelli, Cristina Lorenzi, Sara Spadini, Raffaella Zanardi, Cristina Colombo et al. · 2025 · Acta Psychiatrica Scandinavica
  28. Antipsychotic therapy and suicide risk in patients with treatment-resistant depression: target trial emulation framework study
    Daniel Hsiang‐Te Tsai, Avery Shuei‐He Yang, Zi-Xuan Wong, Albert Tzu-Ming Chuang, Michael Chun‐Yuan Cheng, Chin‐Yao Shen, Shih‐Chieh Shao, Edward Chia‐Cheng Lai · 2025 · The British Journal of Psychiatry
  29. Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature
    Ángela Rocío Acero González, Yahira Guzmán, Nadia Juliana Proaños, Rosa‐Helena Bustos, María Aconcha, Iván Mauricio Guerrero, Laura Alejandra Martinez Calderon, Michael Berk, Seetal Dodd · 2025 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  30. Addressing ‘futility’ in psychiatry: a consensus statement
    Brent Michael Kious, Sarah E. Levitt, Sisco M. P. van Veen, Daniel Z. Buchman, Lucy Costa, Katharina Froelich, Paul Hoff, Anna Lindblad, Suzanne Metselaar, Loïc Moureau et al. · 2026 · Psychological Medicine
  31. Parsing neurobiological heterogeneity in treatment-resistant depression using brain network localization
    kaijie an, Dan Zhang, Meiling Gao, Yue Zhang, Qianqian Zhang, Yi Jiang, Yinfeng Qian, Jiajia Zhu · 2026 · Neurobiology of Disease
  32. Risk factors for suicidal attempts in a sample of outpatients with treatment-resistant depression: an observational study
    Serena Chiara Civardi, Filippo Besana, Giovanni Carnevale Miacca, Filippo Mazzoni, Vincenzo Arienti, Pierluigi Politi, Natascia Brondino, Miriam Olivola · 2024 · Frontiers in Psychiatry
  33. A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression
    Amanda J. F. Tamman, Amit Anand, Sanjay J. Mathew · 2022 · Expert Opinion on Drug Safety
  34. Dopamine and Beyond: Implications of Psychophysical Studies of Intracranial Self-Stimulation for the Treatment of Depression
    Vasilios Pallikaras, Peter Shizgal · 2022 · Brain Sciences
  35. The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
    Seung-Ho Jang, Won‐Myong Bahk, Young Sup Woo, Jeong Seok Seo, Young‐Min Park, Won Kyum Kim, Jong‐Hyun Jeong, Se-Hoon Shim, Jung Goo Lee, Duk‐In Jon et al. · 2023 · Journal of Clinical Medicine
  36. Evaluation, Treatment, and Referral of Treatment-Resistant Depression in Primary Care
    Amit Chopra, James Luccarelli, Jonah N. Cohen, David Mischoulon, Theodore A. Stern · 2023 · The Primary Care Companion For CNS Disorders
  37. Inclusion of the severe and enduring anorexia nervosa phenotype in genetics research: a scoping review
    Sarah Ramsay, Kendra Allison, Heide S. Temples, Luigi Boccuto, Sara M. Sarasua · 2024 · Journal of Eating Disorders
  38. Efficacy of Individualized Homeopathy in Treatment-Resistant Depression
    Noheli Zepeda-Quiroz, Rodolfo Luna Reséndiz, Jacqueline Soto‐Sánchez · 2021 · Cureus
  39. Clinical validation of an adapted Eleveld Model for high-dose propofol treatments for depression
    Carter Lybbert, J. Huang, Keith G. Jones, Brian J. Mickey, Scott C. Tadler, David H. Odell, Jordan W. Stanford, Kai Kück · 2023 · Journal of Clinical Monitoring and Computing
  40. MDepressionKG
    Chengcheng Fu, Xiaobin Jiang, Tingting He, Xingpeng Jiang · 2021 · International Symposium on Artificial Intelligence for Medicine Sciences (ISAIMS)
  41. Dialectical Behavior Therapy as an intervention for Treatment Resistant Depression in adults: A protocol for systematic review and meta-analysis
    Junkes, Larissa, Gherman, Bruno R., Appolinario, Jose Carlos, Nardi, Antonio E. · 2024 · PLoS ONE
  42. Prediction of individual treatment allocation between electroconvulsive therapy or ketamine using the Personalized Advantage Index
    Benjamin Wade, Ryan Pindale, James Luccarelli, Shuang Li, Robert C. Meisner, Stephen J. Seiner, Joan Albert Camprodon, Michael Henry · 2025 · npj Digital Medicine
  43. Differences in High-Frequency Connectivity Among Large-Scale Functional Networks Linked to Major Depressive Disorder and Treatment-Resistant Depression
    Ty Lees, Sarah E. Woronko, Mohan Li, Jason N. Scott, Manuel Kuhn, Shiba M. Esfand, Mario Bogdanov, Brian W. Boyle, Samantha R. Linton, Lauren R. Borchers et al. · 2025 · Biological Psychiatry Global Open Science
  44. Research advances in neuronavigated target localization for repetitive transcranial magnetic stimulation in depression: from standardization to individualized neuromodulation
    Luyang Jiang, C. W. Fung, Calvin Pak Wing Cheng · 2026 · Frontiers in Neuroimaging
  45. The Therapeutic Potential of Psychedelics for Treatment-resistant Depression: Reality or Hallucination? A Systematic Review.
    Natia Horato, Felipe Dalvi-Garcia, P. H. P. Dutra, A. Nardi · 2026 · Journal of Clinical Psychopharmacology
  46. Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study
    Andreas Reif, Yağcıoğlu AE Anıl, István Bitter, Jozefien Buyze, R Frey, Fu DJ, Yordan Godinov, L Haggström, Yerkebulan Kambarov, RE Nielsen et al. · 2026 · European Neuropsychopharmacology
  47. The Effects of Fluoxetine and Agomelatine on Neurocognitive Functions and Sleep in Patients with Major Depressive Disorder
    Esat Fahri Aydın, Mustafa Güleç, Elif Oral, Ali Gökhan Daloğlu · 2024 · Psychiatry and Clinical Psychopharmacology
  48. Advances in repetitive transcranial magnetic stimulation in the treatment of treatment-resistant depression: a comprehensive review
    Haoran Xing, Xiaolei Liu, Yingying Zhang, Jie Wu, Mier Li, Hong Ye, Yu Ding, Weiwei Wang, Zhong Zheng, Tianhao Bao · 2025 · Reviews in the Neurosciences
  49. The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members
    Stephen Ludgate, Anne McGowan, Carla Moran, Roberto Attanasio, Miloš Žarković, Endre Vezekenyi Nagy, Roberto Negro, Enrico Papini, Chagit Adler Cohen, Ersin Akarsu et al. · 2025 · Frontiers in Endocrinology
  50. The effects of rTMS on self-reported quality of life in younger and older adults with major depressive disorder
    Katharina Göke, Jonathan H. Downar, Fidel Vila‐Rodriguez, Zafiris J. Daskalakis, Tarek K. Rajji, Benoit H. Mulsant, Daniel M. Blumberger · 2025 · Psychological Medicine
  51. LSD: Mechanisms and relevance to the treatment of depression
    Amel Bouloufa, Sarah Delcourte, Thomas Delannay, Renaud Rovera, Thorsten Lau, Lionel Moulédous, Ouria Dkhissi‐Benyahya, Bruno Pierre Guiard, Nasser Haddjeri · 2025 · Neuroscience & Biobehavioral Reviews
  52. Prediction model and case analysis of college students' psychological depression based on multi-source online comment mining
    Lixiao Zhu · 2022 · Frontiers in Public Health
  53. Problem Solving in Dance/Movement Therapy Research: Developing an Intervention Protocol for Adults Living with Treatment Resistant Depression
    Neha Christopher · 2024 · American Journal of Dance Therapy
  54. A genetic risk score to predict treatment nonresponse in psychotic depression
    Sophie E. ter Hark, Marieke J. H. Coenen, Cornelis F. Vos, Rob E. Aarnoutse, Willem A. Nolen, Tom K. Birkenhäger, Walter W. van den Broek, Arnt Schellekens, Robbert‐Jan Verkes, Joost Janzing · 2024 · Translational Psychiatry
  55. Clinical prediction instruments available for clinicians treating major depressive disorder: A systematic review
    Dyllis Aimée van Dijk, N G Stoel, Rosa J. Meijer, R J E Repko, Th. Michael van den Boogaard, Henricus Gerardus Ruhé, Jan Spijker, Frenk P. M. L. Peeters · 2025 · Journal of Affective Disorders
  56. Differential impact of extracts from distinct Sceletium tortuosum chemotypes on central neurotransmitter concentrations in C57BL/6 mice
    Catherine H. Kaschula, Anna‐Mart Engelbrecht, Nokwanda Pearl Makunga, Magriet Muller, André J. de Villiers, Kamano Mochoele Dube, Sarel Jacobus Brand, Jo-Anne Stroebel, Willem A. L. van Otterlo, De Wet Wolmarans · 2025 · Journal of Ethnopharmacology
  57. Comparative efficacy and safety of intravenous racemic ketamine, repetitive transcranial magnetic stimulation and electroconvulsive therapy for Stage 2 or higher treatment‐resistant depression: A systematic review and network meta‐analysis
    Itsuki Terao, Takahiro Tsuge, Tomoo Sato, Kaori Endo, Kazumasa Kotake, Masahiro Banno, Yuki Kataoka · 2025 · Psychiatry and Clinical Neurosciences Reports
  58. Efficacy and safety of ketamine maintenance therapy in treatment-resistant depression: A systematic review of treatment protocols and clinical outcomes
    Abdulaziz M. Al-Garni, Gustavo Héctor Vázquez, Tariq Alotibi, Carolina V. Hernandorena, Yuliya Knyahnytska · 2025 · Journal of Affective Disorders
  59. Differential strain sensitivity to low-dose anxiolytic diazepam in anxiety-related behaviour in male Wistar and Wistar-Kyoto, a rat model of endogenous depression
    Akshata T. Inavally, Monika Sadananda · 2024 · Indian Journal of Physiology and Pharmacology
  60. Suicidality Trajectory, Hopelessness, Resilience, and Self-Efficacy Among Patients With Treatment-Resistant Depression in Vietnam
    Phạm Thị Thu Hương, Chia‐Yi Wu, Ming‐Been Lee, Văn Tuân Nguyên, Thi Thu Hien PHAM, Thanh Tung DANG, Son Tung VU, Nguyen Thi Son · 2024 · Journal of Nursing Research
  61. Treatment-resistant depression
    Leesa A. McBroom, Melissa Timmons · 2024 · The Nurse Practitioner
  62. The Effect of Probiotic Lactic Acid Bacteria on the Symptoms of Mental Disorders
    V. Novikova, K. Bondarenko, A. Sazonov, A. S. Rozanov · 2024 · Nanobiotechnology Reports
  63. Deep Brain Stimulation to the Subgenual Cingulate Gyrus for Treatment-Resistant Depression: A Randomized Controlled Trial and 2-Year Long-Term Follow-Up: Stimulation cérébrale profonde du gyrus cingulaire subgénual pour traiter la dépression résistante au traitement : Essai contrôlé à répartition aléatoire et suivi à long terme sur deux ans
    Peter Giacobbe, Sakina J. Rizvi, Amanda K. Ceniti, GEORGE A. TOMLINSON, Gavin J.B. Elias, Jürgen Germann, Rima G. Styra, Andrés M. Lozano, Sidney H. Kennedy · 2025 · The Canadian Journal of Psychiatry
  64. Initiating Antidepressant Medication: What is the Most Important Factor?
    Siegfried F. Kasper · 2022 · Advances in Therapy
  65. Next generation antidepressants with novel mechanisms for treatment resistant depression
    Mu‐Hong Chen, Pei‐Chi Tu, Tung‐Ping Su · 2023 · Progress in brain research
  66. Significant Differences and Experimental Designs Do Not Necessarily Imply Clinical Relevance: Effect Sizes and Causality Claims in Antidepressant Treatments
    Iván Sánchez‐Iglesias, Celia Martín-Aguilar · 2023 · Journal of Clinical Medicine
  67. Influence of Vagus Nerve Stimulation on Mood and Associated Disorders
    Sarah A. Bottari, Alex Rodriguez, John B. Williamson · 2023 · Neuromethods
  68. Opportunities and challenges for the use of deep brain stimulation in the treatment of refractory major depression
    Prashin Unadkat, João Quevedo, Jair C. Soares, Albert J. Fenoy · 2024 · Discover Mental Health
  69. The association of sex and age of treatment-resistant tendency to antidepressants: A cohort study of 325,615 patients with major depressive disorder.
    Dian-Jeng Li, S. Tsai, Tzeng-Ji Chen, Yu-Chen Kao, Chih-Sung Liang, Mu-Hong Chen · 2025 · Journal of Affective Disorders
  70. Associations of Suicide Risk and Community Integration Among Patients With Treatment-Resistant Depression
    Phạm Thị Thu Hương, Chia‐Yi Wu, Ming‐Been Lee, I‐Ming Chen · 2022 · Frontiers in Psychiatry
  71. Reliability and validity of the difficult to treat depression questionnaire (DTDQ)
    Mark A. Zimmerman, Daniel M. Mackin · 2023 · Psychiatry Research
  72. Gender differences in obstructive sleep apnea with comorbid treatment-resistant depression
    Emily Kasurak, Emily R. Hawken, Dušan Kolar, Ruzica Jokic · 2023 · Sleep Science and Practice
  73. Rectangular Repetitive Transcranial Magnetic Monophasic vs Biphasic Stimulation for Major Depressive Disorder: A Randomized Controlled Pilot Trial
    Michelle S. Goodman, Daniel M. Blumberger, Mehran Talebinejad, Adrian D. C. Chan, Robert E. Chen, Tony T. Yang · 2025 · Neuromodulation Technology at the Neural Interface
  74. Further evidence of depressive symptomatology profile predicting treatment outcome
    Maria Luca, Antonina Luca, Alessandro Serretti · 2025 · International Journal of Psychiatry in Clinical Practice
  75. The Relationship Between Subjective Cognitive Decline and Objective Cognitive Performance in Older Adults With Treatment-Resistant Late-Life Depression: The Role of Depression Severity
    Kayla Conaty, Swathi Gujral, Erin McCarty, Ellie Rapp, Noah Schweitzer, Aristotle N. Voineskos, Helen Lavretsky, Joshua S. Shimony, Meryl A. Butters · 2025 · American Journal of Geriatric Psychiatry
  76. Botulinum Toxin: An Unconventional Tool for the Treatment of Depression?
    Matteo Gambini, Riccardo Gurrieri, Gerardo Russomanno, Gianmatteo Cecchini, Federico Mucci, Manuel Glauco Carbone, Donatella Marazziti · 2025 · Brain Sciences
  77. Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT 1A Receptor for Therapeutic Potential in Depression and Anxiety
    Shu-jie Li, Qingning Yuan, Wen‐Yuan Wu, Zhihan Chen, Duo Chen, Hong Shan, Qin-yu Chu, Wenhao Hu, Kai Wu, Tao Liu et al. · 2025 · Research
  78. Phase 2 Clinical Trial of MK-1942, a Negative Allosteric Modulator of Metabotropic Glutamate Receptor 2, for Treatment-Resistant Depression
    Aristide Merola, Yuki Mukai, Tjerk Bueters, Paulette Ceesay, Nicole Dupre, Christine I. Furtek, Gerard Sanacora, Michael E. Thase, Steven D. Targum, Sean M. Smith et al. · 2026 · Journal of Clinical Psychopharmacology
  79. Rethinking the Treatment-Resistant Depression
    Yunfei Tan, Kenji Hashimoto · 2026 · Advances in experimental medicine and biology
  80. Mechanisms and therapeutic potential of ultrasound neuromodulation: Focus on ion channel dynamics
    Shu Cheng, Lei Lei, Fanyuan Meng, Cong Cong Wang, Lijuan Ao, Moxian Chen · 2026 · Neuroscience & Biobehavioral Reviews
  81. Inflammation in treatment-resistant depression: From mechanisms to therapeutics
    Shijin Wu, Xiaofa Gao, Yuyang Zhou, Zibo Lin, C H Chen, Jing Luo, Xiaoyun Liu, Liming Lin, 邵红伟, Song Liu · 2026 · Brain Research Bulletin
  82. Intranasal esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A multicenter real-world longitudinal study
    Filippo Mazzoni, F. Raffone, Arianna De Ciechi, Nicolaja Girone, Monica Macellaro, Giovanni Martinotti, Bernardo Maria Dell’Osso, Vassilis Martiadis, Miriam Olivola · 2026 · Psychiatry Research
  83. Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants
    Joost van Mechelen, Tobias Wieles, Laura G. J. M. Borghans, Marije E. Otto, Maria Joanna Juachon, Amy L. Gillespie, Martijn S. van Noorden, Catherine J. Harmer, Albert M. van Hemert, Joop M. A. van Gerven et al. · 2026 · Journal of Psychopharmacology
  84. Identifying Relational Applications of Deep Brain Stimulation for Treatment Resistant Depression
    Abel Wajnerman Paz · 2023 · Review of Philosophy and Psychology
  85. Playing with a full dex of cards: Treatment resistant depression with suicidality responds to inpatient dextromethorphan therapy
    Itamar Shapira, Bradley G. Burk, Harrison Hill, Brandon Scott Pruett · 2023 · Psychiatry Research Case Reports
  86. Depression roundtable: Is there a role for BoNT?
    Lori H. Kels · 2023 · Toxicon
  87. Utilization of Ketamine for Major Depression
    Ryan Dao, Amit Aggarwal · 2023 · Journal of Exploratory Research in Pharmacology
  88. Vagusnervstimulation (VNS) als Behandlungsoption für Depressionen
    Erhan Kavakbasi, Bernhard Theodor Baune · 2023 · Fortschritte der Neurologie · Psychiatrie
  89. Pharmacological treatment of treatment-resistant depression: Towards evidence-based recommendations
    Stefan Jerotić, Maja Ivković · 2024 · Medicinska istrazivanja
  90. Response to Intermittent Theta Burst Stimulation in Treatment-Resistant Depression
    Mustafa Tonkul, Bernhard Theodor Baune, Erhan Kavakbasi · 2024 · Journal of Ect
  91. Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?
    Shabah M. Shadli, Carina Joy Donegan, Muhammad SS Bin Mohd Fahmi, Bruce R Russell, Paul Glue, Neil McNaughton · 2024 · Journal of Psychopharmacology
  92. Increased functional connectivity between brainstem substructures and cortex in treatment resistant depression
    Anastasia Gaspert, Rasmus Schülke, Zeinab Houjaije, Tabea Bätge, Christopher Sinke, Nima Mahmoudi, Thorsten Folsche, Alborz Bastami, Alexandra Neyazi, Mike Peter Wattjes et al. · 2025 · Psychiatry Research Neuroimaging
  93. Coadministration of scopolamine and mGlu2 receptor negative allosteric modulator VU6001966 as a potential therapeutic approach for depression: Rat frontal cortex neurochemistry and behavior
    Yana Babii, Agnieszka Pałucha-Poniewiera, Krystyna Gołembiowska, Agnieszka Bysiek, Izabela Szpręgiel, Andrzej Pilc · 2025 · Pharmacology Biochemistry and Behavior
  94. Treatment-resistant or difficult-to-treat depression: a consensus on the pharmacotherapy challenges and considerations for the health care system in Greece
    Kyriakos N. Souliotis, Christina Golna, Myrto T. Samara, Eva-Maria Tsapakis, Vasilios P. Bozikas, Thomas N. Hyphantis, Nikolaos Smyrnis, Nikos C. Stefanis · 2025 · Frontiers in Psychiatry
  95. Ketamine Improves Anhedonic Phenotypes Across Species: Translational Evidence From the Probabilistic Reward Task
    Mario Bogdanov, Jason N. Scott, Shiba M. Esfand, Brian W. Boyle, Ty Lees, Mohan Li, Sarah E. Woronko, Samantha R. Linton, Amaya R. Jenkins, Courtney Miller et al. · 2026 · Biological Psychiatry Global Open Science
  96. Concomitant deep brain stimulation and vagus nerve stimulation for treatment-resistant depression: a case report
    Flávio Nascimento, Alexandre Paim Díaz, Marsal Sanches, Albert J. Fenoy, Jair C. Soares, João Quevedo · 2021 · Brazilian Journal of Psychiatry
  97. ECT-Resistant Bipolar Depression Treated with a Single Course of Triple Chronotherapy
    Jadon Webb · 2022 · Case Reports in Psychiatry
  98. The Influence of Research Follow-Up during COVID-19 Pandemic on Mental Distress and Resilience: A Multicenter Cohort Study of Treatment-Resistant Depression
    Phạm Thị Thu Hương, Chia‐Yi Wu, Ming‐Been Lee, Wei‐Chieh Hung, I‐Ming Chen, Hsi‐Chung Chen · 2022 · International Journal of Environmental Research and Public Health
  99. Schwangerschaft und Postpartalzeit
    Anna Linda Leutritz, Sarah Kittel‐Schneider · 2022 · Springer eBooks
  100. Defining treatment-resistant depression, difficult-to-treat depression, and staging treatment intensity
    Hamish McAllister-Williams · 2022 · Elsevier eBooks